These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 27074560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Analysis of expression of cancer stem cell-related markers in orbital adenoid cystic carcinoma].
    Lin TT, Zhu LM, He YJ, Zhang H.
    Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):703-8. PubMed ID: 22169609
    [Abstract] [Full Text] [Related]

  • 8. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
    Liu TJ, Sun BC, Zhao XL, Zhao XM, Sun T, Gu Q, Yao Z, Dong XY, Zhao N, Liu N.
    Oncogene; 2013 Jan 31; 32(5):544-53. PubMed ID: 22469978
    [Abstract] [Full Text] [Related]

  • 9. Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma.
    Li W, Tamamura R, Wang B, Liu Q, Liu H, Liu T, Katase N, Xiao J, Nagatsuka H.
    Biomed Res Int; 2014 Jan 31; 2014():132349. PubMed ID: 24804195
    [Abstract] [Full Text] [Related]

  • 10. MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.
    Panaccione A, Zhang Y, Ryan M, Moskaluk CA, Anderson KS, Yarbrough WG, Ivanov SV.
    Stem Cell Res; 2017 May 31; 21():160-166. PubMed ID: 28500913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HSP27 associates with epithelial-mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma.
    Chen W, Ren X, Wu J, Gao X, Cen X, Wang S, Sheng S, Chen Q, Tang YJ, Liang XH, Tang YL.
    J Cell Mol Med; 2018 Apr 31; 22(4):2283-2298. PubMed ID: 29424489
    [Abstract] [Full Text] [Related]

  • 13. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
    Li Y, Sun B, Zhao X, Zhang D, Wang X, Zhu D, Yang Z, Qiu Z, Ban X.
    Exp Mol Pathol; 2015 Apr 31; 98(2):136-44. PubMed ID: 25661888
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH, Hur W, Hong SW, Kim JH, Kim SM, Lee EB, Yoon SK.
    Oncol Rep; 2017 Feb 31; 37(2):813-822. PubMed ID: 27959451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
    Sun ZJ, Chen G, Zhang W, Hu X, Huang CF, Wang YF, Jia J, Zhao YF.
    J Pharmacol Exp Ther; 2010 Aug 31; 334(2):500-12. PubMed ID: 20484154
    [Abstract] [Full Text] [Related]

  • 19. C-kit induces epithelial-mesenchymal transition and contributes to salivary adenoid cystic cancer progression.
    Tang YL, Fan YL, Jiang J, Li KD, Zheng M, Chen W, Ma XR, Geng N, Chen QM, Chen Y, Liang XH.
    Oncotarget; 2014 Mar 30; 5(6):1491-501. PubMed ID: 24721839
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.